Nuveen’s Novartis NVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$19.5M Buy
+124,459
New +$18.7M ﹤0.01% 1278
2020
Q2
Sell
-6,522
Closed -$538K 3340
2020
Q1
$538K Sell
6,522
-5,150
-44% -$459K ﹤0.01% 2740
2019
Q4
$1.1M Sell
11,672
-1,188
-9% -$107K ﹤0.01% 2650
2019
Q3
$1.12M Buy
12,860
+437
+4% +$39.2K ﹤0.01% 2652
2019
Q2
$1.13M Sell
12,423
-1,864
-13% -$158K ﹤0.01% 2685
2019
Q1
$1.23M Buy
14,287
+684
+5% +$54.9K 0.01% 708
2018
Q4
$1.05M Buy
+13,603
New +$1.06M 0.01% 710
2017
Q3
Sell
-4,250
Closed -$318K 1143
2017
Q2
$318K Buy
+4,250
New +$301K ﹤0.01% 1014
2017
Q1
Sell
-3,212
Closed -$208K 1447
2016
Q4
$208K Buy
+3,212
New +$208K ﹤0.01% 1443

Other funds holding NVS

Nuveen's NVS Position: Q2 2026 in Review

Nuveen opened a new position in Novartis (NVS) in Q2 2026: 124,459 shares worth $19.5M. The stake represents ﹤0.01% of the portfolio and ranks #1278 among its holdings. This is a return to the name: Nuveen previously reported a position in NVS as recently as Q1 2020.

Nuveen first reported a position in NVS in Q4 2016 and has held it in 9 quarters since. 1,620 funds tracked by Wall St. Rank hold NVS as of Q2 2026.

  • Nuveen held 124,459 shares of Novartis worth $19.5M as of Q2 2026.
  • Novartis was a new Nuveen position in Q2 2026.
  • Novartis made up ﹤0.01% of Nuveen's portfolio in Q2 2026, its #1278 holding.
  • Nuveen first reported a position in Novartis in Q4 2016 and has held it in 9 quarters since.
  • 1,620 funds tracked by Wall St. Rank held Novartis as of Q2 2026.

Based on Nuveen's 13F filing for Q2 2026, filed 11 Aug 2026.